IntroductionThe mammalian ribonuclease inhibitor (RI) is a 50-kDa cytosolic protein that binds to pancreatic-type ribonucleases with femtomolar affinity and renders them inactive (for other reviews, see (1-5)). Complexes formed by RI and its target ribonucleases are among the tightest of known biomolecular interactions. The three-dimensional structure of RI is likewise remarkable, being characterized by alternating units of α-helix and β-strand that form a striking horseshoe shape (Fig. 1A) (6). The repeating structural units of RI possess a highly repetitive amino acid sequence that is rich in leucine residues (7,8). These leucine-rich repeats (LRRs) are present in a large family of proteins that are distinguished by their display of vast surface areas to foster protein protein interactions (9-12). The unique structure and function of RI have resulted in its emergence as the central protein in the study of LRRs, as well as its widespread use as a laboratory reagent to eliminate ribonucleolytic activity (13).The biological role of RI is not known in its entirety. The ribonucleases recognized by RI are secreted proteins, whereas RI resides exclusively in the cytosol. Nevertheless, RI affinity has been shown to be the primary determinant of ribonuclease cytotoxicity: only ribonucleases that evade RI can kill a cell (for reviews, see (14)(15)(16)(17)). In addition, the complex of RI with human angiogenin (ANG), which stimulates neovascularization by activating transcription in the nucleus (18,19), is the tightest of known RI·ribonuclease complexes. Yet, a role for RI in angiogenesis is not clear. Also intriguing are the 30-32 cysteine residues of RI, all of which must remain reduced for the protein to retain activity (20). These observations have lead researchers to hypothesize multiple biological roles for RI: (1) to protect cells from invading ribonucleases, (2) to regulate or terminate the activity of ribonucleases with known intracellular functions, and (3) to monitor the oxidation state of the cell in response to factors such as aging and oxidative stress. Here, we review the salient features of RI biochemistry and structure and thereby provide a context for examining the roles of RI in biology.
I. Biochemical PropertiesThe inhibitory activity of RI in guinea pig liver extracts was discovered in 1952 (21). This activity was inactivated by proteases, heat, or sulfhydryl-group modification, and was sensitive to changes in pH (for a review, see (22)). In addition, the inhibitory activity was isolated in the supernatant fraction during a high-speed centrifugation, indicative of cytoplasmic localization. In the 1970's, techniques were developed to purify RI to homogeneity, enabling its biochemical characterization (23,2). Since then, RI has been isolated from numerous mammalian sources, including brain (24-26), liver (27,28,26), testis (29), and erythrocytes (30).
A. PurificationRI is particularly abundant in mammalian placenta and liver, which have served as the major source of RI for purification. Human placenta...